FDA approves first new hemophilia treatment in nearly 20 years

TRENTON, N.J. — U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia. The Food and Drug Administration on Thursday approved Hemlibra, a weekly self-injection for hemophilia A patients who have developed resistance to standard medicines for preventing bleeding episodes. The list price will...

from New York Post http://ift.tt/2zMVj6n